RNF213 and multiminicore myopathy: In the future, generation of CRISPR-mediated RNF213 point mutation- or patient-derived 3D models, incorporating patient- or iPSC-derived endothelial cells carrying specific point mutations in the RNF213 gene, will help us to better understand MMD pathogenesis and other RNF213-associated vascular abnormalities.